Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Gao

Showing results (411-420 of 417) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 417 results.
Diabetes, Obesity & Metabolism|January 29, 2024
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation studyGui-Ling Chen, Yang Liu, Xue-Feng Gao, et al.
Human Vaccines & Immunotherapeutics|December 19, 2023
Safety and immunogenicity of primary vaccination with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: Two randomized, observer-blinded, placebo-controlled and dose-escalation phase 1 clinical trialsGui-Ling Chen, Yuan-Zheng Qiu, Kai-Qi Wu, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Acute degron-mediated RUNX1 loss reprograms enhancer activity to epigenetically drive epithelial destabilization and initiate cancer hallmarksAndrew J Fritz, Haley Greenyer, Louis Dillac, et al.
Vaccine|November 4, 2023
Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adultsGui-Ling Chen, Xu-Ya Yu, Li-Ping Luo, et al.
The Lancet. Microbe|January 31, 2022
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trialGui-Ling Chen, Xiao-Feng Li, Xia-Hong Dai, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2023
Early autoimmunity and outcome in virus encephalitis: a retrospective study based on tissue-based assayDing Liu, Pei-Hao Lin, Hui-Lu Li, et al.
Imeta|January 1, 2025
<i>iMeta</i> Conference 2024: Building an innovative scientific research ecosystem for microbiome and One HealthYao Wang, Huiyu Hou, Hao Luo, et al.
Pageof 42

Showing results (411-420 of 417) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 417 results.
Diabetes, Obesity & Metabolism|January 29, 2024
Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation studyGui-Ling Chen, Yang Liu, Xue-Feng Gao, et al.
Human Vaccines & Immunotherapeutics|December 19, 2023
Safety and immunogenicity of primary vaccination with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants aged 18 years or more: Two randomized, observer-blinded, placebo-controlled and dose-escalation phase 1 clinical trialsGui-Ling Chen, Yuan-Zheng Qiu, Kai-Qi Wu, et al.
Biorxiv : the Preprint Server for Biology|April 3, 2026
Acute degron-mediated RUNX1 loss reprograms enhancer activity to epigenetically drive epithelial destabilization and initiate cancer hallmarksAndrew J Fritz, Haley Greenyer, Louis Dillac, et al.
Vaccine|November 4, 2023
Phase I study of a non-S2P SARS-CoV-2 mRNA vaccine LVRNA009 in Chinese adultsGui-Ling Chen, Xu-Ya Yu, Li-Ping Luo, et al.
The Lancet. Microbe|January 31, 2022
Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trialGui-Ling Chen, Xiao-Feng Li, Xia-Hong Dai, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|May 24, 2023
Early autoimmunity and outcome in virus encephalitis: a retrospective study based on tissue-based assayDing Liu, Pei-Hao Lin, Hui-Lu Li, et al.
Imeta|January 1, 2025
<i>iMeta</i> Conference 2024: Building an innovative scientific research ecosystem for microbiome and One HealthYao Wang, Huiyu Hou, Hao Luo, et al.
Pageof 42